Continued Hesitancy for Clinical Trial Participation Among Minorities
Sensis completed its first survey on diversity in medical research and found minorities grossly underrepresented in clinical trials. Even though the FDA will require 15% diversity in federal drug trials for approval, African Americans and Hispanics are the least likely to take part according to research conducted by Sensis. “Greater compensation, more transparency, and assurances … Read more

























